instruction
stringlengths
30
82
output
stringlengths
13
790
Which condition is asociated with RS1177544722 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1177544722 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1177544722 SNP.
In which chromosome is RS1177544722 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS1177544722 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS1177544722 SNP, is it benign or pathogenic?
It is Likely benign.
How long is the variation length for RS1177544722 SNP?
The variation length is 2 base pairs.
What is the origin for RS1177544722 SNP?
The origin is unknown.
What is the type of genetic variation for RS1177544722 SNP?
The variation is a Deletion.
What is the genetic molecular consequence for RS1177544722 SNP?
The resulting gene consequence is a frameshift variant.
Which condition is asociated with RS1370123231 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1370123231 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1370123231 SNP.
In which chromosome is RS1370123231 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS1370123231 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS1370123231 SNP, is it benign or pathogenic?
It is Uncertain significance.
How long is the variation length for RS1370123231 SNP?
The variation length is 8 base pairs.
What is the origin for RS1370123231 SNP?
The origin is unknown.
What is the type of genetic variation for RS1370123231 SNP?
The variation is a Insertion.
What is the genetic molecular consequence for RS1370123231 SNP?
The resulting gene consequence is a frameshift variant.
Which condition is asociated with RS553094345 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS553094345 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS553094345 SNP.
In which chromosome is RS553094345 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS553094345 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS553094345 SNP, is it benign or pathogenic?
It is Benign.
How long is the variation length for RS553094345 SNP?
The variation length is 1 base pairs.
What is the origin for RS553094345 SNP?
The origin is unknown.
What is the type of genetic variation for RS553094345 SNP?
The variation is a Duplication.
What is the genetic molecular consequence for RS553094345 SNP?
The resulting gene consequence is a intron variant.
Which condition is asociated with RS553094345 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS553094345 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS553094345 SNP.
In which chromosome is RS553094345 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS553094345 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS553094345 SNP, is it benign or pathogenic?
It is Benign.
How long is the variation length for RS553094345 SNP?
The variation length is 2 base pairs.
What is the origin for RS553094345 SNP?
The origin is unknown.
What is the type of genetic variation for RS553094345 SNP?
The variation is a Duplication.
What is the genetic molecular consequence for RS553094345 SNP?
The resulting gene consequence is a intron variant.
Which condition is asociated with RS553094345 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS553094345 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS553094345 SNP.
In which chromosome is RS553094345 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS553094345 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS553094345 SNP, is it benign or pathogenic?
It is Benign.
How long is the variation length for RS553094345 SNP?
The variation length is 3 base pairs.
What is the origin for RS553094345 SNP?
The origin is unknown.
What is the type of genetic variation for RS553094345 SNP?
The variation is a Duplication.
What is the genetic molecular consequence for RS553094345 SNP?
The resulting gene consequence is a intron variant.
Which condition is asociated with RS553094345 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS553094345 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS553094345 SNP.
In which chromosome is RS553094345 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS553094345 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS553094345 SNP, is it benign or pathogenic?
It is Benign.
How long is the variation length for RS553094345 SNP?
The variation length is 14 base pairs.
What is the origin for RS553094345 SNP?
The origin is unknown.
What is the type of genetic variation for RS553094345 SNP?
The variation is a Duplication.
What is the genetic molecular consequence for RS553094345 SNP?
The resulting gene consequence is a intron variant.
Which condition is asociated with RS553094345 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS553094345 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS553094345 SNP.
In which chromosome is RS553094345 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS553094345 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS553094345 SNP, is it benign or pathogenic?
It is Benign.
How long is the variation length for RS553094345 SNP?
The variation length is 22 base pairs.
What is the origin for RS553094345 SNP?
The origin is unknown.
What is the type of genetic variation for RS553094345 SNP?
The variation is a Duplication.
What is the genetic molecular consequence for RS553094345 SNP?
The resulting gene consequence is a intron variant.
Which condition is asociated with RS553094345 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS553094345 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS553094345 SNP.
In which chromosome is RS553094345 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS553094345 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS553094345 SNP, is it benign or pathogenic?
It is Benign.
How long is the variation length for RS553094345 SNP?
The variation length is 2 base pairs.
What is the origin for RS553094345 SNP?
The origin is unknown.
What is the type of genetic variation for RS553094345 SNP?
The variation is a Deletion.
What is the genetic molecular consequence for RS553094345 SNP?
The resulting gene consequence is a intron variant.
Which condition is asociated with RS553094345 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS553094345 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS553094345 SNP.
In which chromosome is RS553094345 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS553094345 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS553094345 SNP, is it benign or pathogenic?
It is Benign.
How long is the variation length for RS553094345 SNP?
The variation length is 3 base pairs.
What is the origin for RS553094345 SNP?
The origin is unknown.
What is the type of genetic variation for RS553094345 SNP?
The variation is a Deletion.
What is the genetic molecular consequence for RS553094345 SNP?
The resulting gene consequence is a intron variant.
Which condition is asociated with RS1593539077 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593539077 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593539077 SNP.
In which chromosome is RS1593539077 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS1593539077 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS1593539077 SNP, is it benign or pathogenic?
It is Benign.
How long is the variation length for RS1593539077 SNP?
The variation length is 8 base pairs.
What is the origin for RS1593539077 SNP?
The origin is unknown.
What is the type of genetic variation for RS1593539077 SNP?
The variation is a Insertion.
What is the genetic molecular consequence for RS1593539077 SNP?
The resulting gene consequence is a intron variant.
Which condition is asociated with RS1593539493 SNP?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593539493 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593539493 SNP.
In which chromosome is RS1593539493 SNP located?
It is located in the chromosome 13.
Which methods support the evidence found for the RS1593539493 SNP?
Associated methods are: clinical testing.
What is the clinical significance of RS1593539493 SNP, is it benign or pathogenic?
It is Pathogenic.
How long is the variation length for RS1593539493 SNP?
The variation length is 1 base pairs.
What is the origin for RS1593539493 SNP?
The origin is unknown.
What is the type of genetic variation for RS1593539493 SNP?
The variation is a single nucleotide variant.
What is the genetic molecular consequence for RS1593539493 SNP?
The resulting gene consequence is a nonsense.
Which condition is asociated with DUP820580?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsDUP820580. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/DUP820580.
In which chromosome is DUP820580 located?
It is located in the chromosome 13.
Which methods support the evidence found for the DUP820580?
Associated methods are: clinical testing.
What is the clinical significance of DUP820580, is it benign or pathogenic?
It is Likely pathogenic.
How long is the variation length for DUP820580?
The variation length is 12396 base pairs.
What is the origin for DUP820580?
The origin is germline.
What is the type of genetic variation for DUP820580?
The variation is a Duplication.
Which condition is asociated with DEL820581?
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsDEL820581. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/DEL820581.
In which chromosome is DEL820581 located?
It is located in the chromosome 13.
Which methods support the evidence found for the DEL820581?
Associated methods are: clinical testing.
What is the clinical significance of DEL820581, is it benign or pathogenic?
It is Pathogenic.
How long is the variation length for DEL820581?
The variation length is 27099 base pairs.